-transparent.png){kind=logo}
GP53,633 is a new basic non-steroidal anti-inflammatory drug showing analgesic and anti-inflammatory activity in animal models. Pharmacokinetic studies in 6 patients with rheumatoid arthritis show it to be rapidly absorbed with a short half life (approximately 2 hours). No change in pharmacokinetics is seen over a two week treatment period. Clinical parameters of inflammation were reduced and no adverse reactions were seen.
Related Publications
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
January 1987,
European journal of rheumatology and inflammation,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
January 1985,
Current medical research and opinion,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
January 1987,
Terapevticheskii arkhiv,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
May 1985,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
January 1987,
Pharmacology & therapeutics,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
December 1994,
Revue du rhumatisme (Ed. francaise : 1993),
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
December 2022,
Acta clinica Croatica,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
January 1984,
Terapevticheskii arkhiv,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
September 1988,
Minerva medica,
S Wanwimolruk, and
D Thomas, and
D J Birkett, and
J O Miners, and
P M Brooks
July 1978,
The Medical journal of Australia,
